BR0108735A - Proteção in ovo contra bronquite infecciosa - Google Patents

Proteção in ovo contra bronquite infecciosa

Info

Publication number
BR0108735A
BR0108735A BR0108735A BR0108735A BR0108735A BR 0108735 A BR0108735 A BR 0108735A BR 0108735 A BR0108735 A BR 0108735A BR 0108735 A BR0108735 A BR 0108735A BR 0108735 A BR0108735 A BR 0108735A
Authority
BR
Brazil
Prior art keywords
infectious bronchitis
protection against
ovo
against infectious
ovo protection
Prior art date
Application number
BR0108735A
Other languages
English (en)
Inventor
Berend J Jongsma
Frans G Davelaar
Marinus Wijnand Weststrate
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/775,750 external-priority patent/US20010046500A1/en
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0108735A publication Critical patent/BR0108735A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

"PROTEçãO IN OVO CONTRA BRONQUITE INFECCIOSA". A presente invenção refere-se a processos e composições para proteger animais hospedeiros (por exemplo, galinhas) contra a exposição a vírus de bronquite infecciosa virulento. A administração in ovo de cepas avirulentas, vivas, de IB em níveis de dosagem em uma base por ovo proporciona uma vacinação eficaz e eficiente tendo características aceitáveis de segurança e de eficácia.
BR0108735A 2000-02-29 2001-02-15 Proteção in ovo contra bronquite infecciosa BR0108735A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51573200A 2000-02-29 2000-02-29
US09/775,750 US20010046500A1 (en) 2000-02-29 2001-02-02 In ovo protection against infectious bronchitis
PCT/US2001/004792 WO2001064244A2 (en) 2000-02-29 2001-02-15 In ovo protection against infectious bronchitis

Publications (1)

Publication Number Publication Date
BR0108735A true BR0108735A (pt) 2002-12-17

Family

ID=27058588

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108735A BR0108735A (pt) 2000-02-29 2001-02-15 Proteção in ovo contra bronquite infecciosa

Country Status (20)

Country Link
EP (2) EP1259257B1 (pt)
JP (1) JP2003529565A (pt)
CN (1) CN1406135A (pt)
AR (1) AR027558A1 (pt)
AT (1) ATE463253T1 (pt)
AU (1) AU2001237016A1 (pt)
BR (1) BR0108735A (pt)
CA (1) CA2401145A1 (pt)
CY (1) CY1110544T1 (pt)
DE (1) DE60141743D1 (pt)
DK (1) DK1259257T3 (pt)
ES (1) ES2341841T3 (pt)
IL (1) IL151039A0 (pt)
MX (1) MXPA02008254A (pt)
NO (1) NO20024100L (pt)
NZ (1) NZ520761A (pt)
PL (1) PL365447A1 (pt)
PT (1) PT1259257E (pt)
WO (1) WO2001064244A2 (pt)
YU (1) YU65102A (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR031405A1 (es) 2000-11-21 2003-09-24 Wyeth Corp Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
WO2004078203A2 (en) * 2003-03-03 2004-09-16 Akzo Nobel N.V. Infectious bronchitis virus with an altered spike gene
WO2007072916A1 (ja) * 2005-12-22 2007-06-28 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 卵内接種用ワクチン
CN109641043A (zh) 2016-06-16 2019-04-16 勃林格殷格翰动物保健有限公司 针对感染性支气管炎病毒的疫苗
CN112996537A (zh) 2018-10-31 2021-06-18 勃林格殷格翰动物保健有限公司 具有异源刺突蛋白的4/91 ibv疫苗
CN112996536A (zh) 2018-10-31 2021-06-18 勃林格殷格翰动物保健有限公司 具有异源刺突蛋白的h52 ibv疫苗
CN114126645A (zh) 2019-05-10 2022-03-01 勃林格殷格翰动物保健有限公司 冠状病毒刺突蛋白的修饰的s1亚基
US20220213148A1 (en) 2019-05-10 2022-07-07 Boehringer Ingelheim Vetmedica Gmbh Modified s2 subunit of the coronavirus spike protein
MX2021013728A (es) 2019-05-10 2021-12-10 Boehringer Ingelheim Vetmedica Gmbh Ibv atenuado con tropismo de cultivo celular y tisular extendido.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE196773T1 (de) * 1993-07-30 2000-10-15 Akzo Nobel Nv Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff
US6506385B1 (en) * 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith

Also Published As

Publication number Publication date
EP2198883A1 (en) 2010-06-23
AR027558A1 (es) 2003-04-02
PT1259257E (pt) 2010-06-01
WO2001064244A2 (en) 2001-09-07
JP2003529565A (ja) 2003-10-07
CA2401145A1 (en) 2001-09-07
NO20024100D0 (no) 2002-08-28
IL151039A0 (en) 2003-04-10
MXPA02008254A (es) 2003-02-06
CY1110544T1 (el) 2015-04-29
EP1259257A2 (en) 2002-11-27
EP1259257B1 (en) 2010-04-07
WO2001064244A3 (en) 2002-01-31
AU2001237016A1 (en) 2001-09-12
PL365447A1 (en) 2005-01-10
DE60141743D1 (de) 2010-05-20
YU65102A (sh) 2005-09-19
ATE463253T1 (de) 2010-04-15
DK1259257T3 (da) 2010-06-14
NO20024100L (no) 2002-10-09
CN1406135A (zh) 2003-03-26
NZ520761A (en) 2004-10-29
ES2341841T3 (es) 2010-06-29

Similar Documents

Publication Publication Date Title
HRP20050192B1 (hr) Cjepivo za infekcije dišnog i spolnog sustava kod goveda
BR9605153A (pt) Vacina de combinação para uso na proteção de galináceos contra a doença de newcastle kit de vacinação para imunizar galináceos contra a doença de newcastle e processo para a prevenção da doença de newcastle em galináceos
AR020134A1 (es) Antigenos inmunologicos contra el virus herpes simplex y metodos para el uso de los mismos
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
CY1110544T1 (el) Προστασια εντος ωου εναντι λοιμωδους βρογχιτιδας
BR0211492A (pt) Vacina para west nile
CA2339089A1 (en) Cold-adapted equine influenza viruses
CY1107188T1 (el) Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης
ES2152292T3 (es) Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91.
UY28274A1 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
BR0000190A (pt) Reovìrus de ave, processos para a preparação do mesmo, para controlar condições de doença que resultem de uma infecção de reovìrus de ave em aves domésticas e para a preparação de uma vacina para o uso na proteção de aves domésticas contra condições de doença que resultem de uma infecção de reovìrus de ave, e, vacina para o uso na proteção de aves domésticas.
UY26450A1 (es) Virus atenuados e inocuos de la diarrea vírica bovina para uso en vacas gestantes.
AR048671A1 (es) Procedimiento de vacunacion contra la infeccion testicular por bvdv
WO1999053950A3 (en) Live vaccines and methods of treatment therewith
Pastoret et al. Veterinary vaccines for animal and public health
BRPI0508660A (pt) composição de vacina eficaz na prevenção ou melhora da infecção por vìrus da doença bursal infecciosa; composição de vacina; isolado antigênico do vìrus da doença bursal infecciosa; e método para induzir proteção contra infecção do vìrus da doença bursal infecciosa
WO2004030614A3 (en) Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor
TW200503755A (en) Avian vaccine composition for the protection of poultry against disease and infection caused by e. coli and salmonella
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
HU0100908D0 (en) Chicken anaemia viruses of low pathogenicity
BR0115507A (pt) Métodos e vacinas para provisão de proteção in ovo contra rinotraqueìte de peru
ES2102370T3 (es) Composicion antiparasitaria para uso animal.
BR0101523A (pt) Pestivìrus, vacina, e, processos para imunizarcontra doença induzida por pestivìrus e parafabricar uma vacina para a proteção de um animalcontra um pestivìrus
BR0314349A (pt) Astrovìrus tipo 2 de galinha (castv-2), cultura de células, vacina para uso na proteção de aves domésticas contra doenças causadas pela infecção por astrovìrus aviário, e, métodos para a preparação de material antìgeno de castv-2, para a preparação de uma vacina e para a proteção de aves domésticas, em particular galinhas, contra doença causada pela infecção por astrovìrus aviário
BR0003164A (pt) Mutante ndv, vacinas viva e inativada contra doença de newcastle em aves, uso de um mutante ndv, e, processo de proteção de aves contra nd

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009